Review of Testim® gel

Expert Opinion on Pharmacotherapy

Volumn 7, Issue 4, 2006, Pages 477-484

  McNicholas, Tom ^a,b   Ong, Teng ^c  

^a LISTER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

Author keywords

Hypogonadism; Late onset hypogonadism; Testim gel; Testosterone; Testosterone gel

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DUTASTERIDE; FINASTERIDE; HEMOGLOBIN; PHOSPHODIESTERASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; VITAMIN D; ANDROGEN;

ACNE; AGING; APPLICATION SITE RASH; APPLICATION SITE REACTION; BODY COMPOSITION; BONE DENSITY; CLINICAL TRIAL; DIGITAL RECTAL EXAMINATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; GYNECOMASTIA; HEMATOCRIT; HEMATOLOGIC DISEASE; HORMONAL THERAPY; HORMONE DEFICIENCY; HOT FLUSH; HUMAN; HYPERTENSION; HYPOGONADISM; INSOMNIA; LACRIMATION DISORDER; LIBIDO DISORDER; MALE; MOOD; MOOD DISORDER; PATIENT MONITORING; PENIS ERECTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SCORING SYSTEM; SENILE OSTEOPOROSIS; SEXUAL AROUSAL; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SMELLING DISORDER; SYMPTOMATOLOGY; TASTE DISORDER; TESTOSTERONE BLOOD LEVEL; ADULT; AGED; BLOOD; CONTROLLED CLINICAL TRIAL; GEL; HORMONE SUBSTITUTION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANDROGENS; GELS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 33644906139     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.7.4.477     Document Type: Review

References (28)

1. MALKIN CJ, PUGH PJ, MORRIS PD et al.: Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart (2004) 90(8):871-876.
2. BARRETT-CONNOR E, GOODMAN-GRUEN D, PATAY B. Endogenous sex hormones and cognitive function in older men. J. Clin. Endocrinol. Metab. (1999)84(10):3681-3685.
3. SEIDMAN SN: Testosterone deficiency and mood in aging men: pathogenic and therapeutic interactions. World J. Biol. Psychiatry (2003)4(1):14-20.
4. POPE HG JR, COHANE GH, KANAYAMA G, SIEGEL AJ, HUDSON JI: Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am. J. Pychiatry (2003) 160(1):105-111.
5. MORALES A, LUNENFELD B: Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male (2002) 5(2):74-86.
6. BHASIN S, STORER TW, BERMAN N et al.: Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J. Clin. Endocrinol Metab. (1997) 82(2):407-413.
7. SCHUBERT M, MINNEMAN T, HUBLER D et al.: Intramuscular restosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.J. Clin. EndocrinoL Metab. (2004) 89(11):5429-5434.
8. KORBONITS M, SLAWIK M, CULLEN D et al.: A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males. J. Clin. Endocrinol. Metab. (2004) 89(5):2039-2043.
9. SNYDER PJ, PEACHEY H, BERLIN JA et al.: Effects of testosterone replacement in hypogonadal men. J Clin. Endocrinol Metab. (2000) 85(8):2670-2677.
10. WANG C, SWEDLOFF RS, IRANMANESH A et al.: Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. Testosterone Gel Study Group. J. CLin EndocrinoL Metab (2000) 85(8):2839-2853.
11. MCNICHOLAS TA, DEAN JD, MULDER H, CARNEGIE C, JONES NA: A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int. (2003) 91(1):69-74.
12. STEIDLE C, SCHWARTZ S, JACOBY K et al.: AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function. J. Clin. Endocrinol. Metab. (2003) 88(6):2673-2681.
13. MARBURY T, HAMILL E, BACHAND R, SEBREE T, SMITH T: Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel. Biopharm. Drug Dispos. (2003) 24(3):115-120.
14. DEAN A CARNEGIE C, RODZVILLAJ, SMITH T: Long-term effects of Testim 1% testosterone gel in hypogonadal men. Reviews in Urology (2004) 6(Suppl. 6):S22-S29.
15. LOIZIDFS E, SWIERZEWSKI M, O'NEILL C, GRIESSER J, SMITH T: Early response time in sexual activity and mood to testostcrone gel replacement in hypogonadal males from die Testim 1 START study. Rev. Urol (2004) 6(Suppl. 6):S16-S21.
16. LEE KK, BERMAN N, ALEXANDER GM et al.: A simple self-report diary for assessing psychosexual function in hypogonadal men. J. Androl. (2003) 24(5):688-698.
17. TENOVER JL: Testosterone and the aging male.J. Androl (1997) 18(2):103-106.
18. STANFORD J, STEPHENSON R, COYLE L et al.: Prostate Cancer Trends 1973-1995. SEER Program, National Cancer Institute. NIH Pub. No. 99-4543. Bethesda, MD (1999).
19. SAIRAM K, KULINSKAYA E, BOUSTEAD G, HANBURY D, MCNICHOLAS T. Prevalence of undiagnosed prostate cancer in men presenting with erectile dysfunction. BJUInt. (2002) 89(3):261-263.
20. VON ECKARDSTEIN S, NIESCHLAG E: Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a Phase II study. J. Androl (2002) 23(3):419-425.
21. WANG C, CUNNINGHAM G, DOBS A et al.: Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J. Clin. Endocrinol Metab. (2004) 89(5):2085-2098.
22. VERMEULEN A, VERDONCK L, KAUFMAN JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol Metab. (1999) 84(10):3666-3672.
23. SHABSIGH R, KAUFMAN JM, STEIDLE C, PADMA-NATHAN H: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J. Urol. (2004) 172(2):658-663.
24. KALINCHENKO SY, KOZLOV GI, GONTCHAROV NP, KATSIYA GV: Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male (2003) 6(2):94-99.
25. VOM ECKARDSTEIN S, NOE G, BRACHE V et al.: A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J. Clin. Endocrinol. Metab. (2003) 88(11):5232-5239.
26. ROBERTS SE, GOLDCRE MJ: Time trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database study. Br. Med. J. (2003) 327(7418):771-775.
27. AMORY JK, WATTS NB, EASLEY KA et al.: Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J. Clin. Endocrinol. Metab. (2004) 89(2):503-510.
28. GERSTENBLUTH RE, MANIAN PN, CORTY EW, SEFTEL AD: Prostatespecific antigen changes in hypogonadal men treated with testosterone replacement. J. Androl. (2002) 23(6):922-926.